Objectives: Medication side effects are common, often leading to reduced quality of life, nonadherence and financial costs for health services. Many side effects are the result of a psychologically-mediated 'nocebo effect'. This review identifies the risk factors involved in the development of nocebo effects.Methods: Web of Science, Scopus, Medline, PsychINFO, Journals @ Ovid full text, and Global health were searched using the terms "nocebo" and "placebo effect". To be included, studies must have exposed people to an inert substance and have assessed one or more baseline or experimental factor(s) on its ability to predict symptom development in response to the inert exposure.Results: 89 studies were included, 70 used an experimental design and 19 used a prospective design, identifying 14 different categories of risk factor. The strongest predictors of nocebo effects were a higher perceived dose of exposure, explicit suggestions that the exposure triggers arousal or symptoms, observing people experiencing symptoms from the exposure, and higher expectations of symptoms.Conclusions: In order to reduce nocebo induced symptoms associated with medication or other interventions clinicians could: reduce expectations of symptoms, limit suggestions of symptoms, correct unrealistic dose perceptions, and reduce exposure to people experiencing side effects. There is some evidence that we should do this especially for persons with at-risk personality types, though exactly which personality types these are requires further research.These suggestions have a downside in terms of consent and paternalism, but there is scope to develop innovative ways to reduce nocebo effects without withholding information.Key words: nocebo effect, predictors, symptoms, inert exposure, review 3 Adverse drug reactions (ADRs) are common (Davies et al., 2009), and can have serious implications in terms of patient well-being and adherence (Ammassari et al., 2001) as well as significant financial costs for health services (Monguio, Otero, & Rovira, 2003; NICE, 2009). However, ADRs are not always related to the physiological action of the medication (Faasse & Petrie, 2013). Only 10.9% of reported ADRs to commonly prescribed drugs are clearly attributable to the medication (de Frutos Hernansanz et al., 1994). It is thought a nocebo effect may play a role in the formation of other apparent side effects (Barsky, Saintfort, Rogers, & Borus, 2002). As well as medication side effects, nocebo effects have been implicated in symptoms attributed to technological exposures such as electro-magnetic fields (EMF) from mobile phones and Wi-Fi (Baliatsas et al., 2012; Rubin, Cleare, & Wessely, 2008). A nocebo effect is the experience of negative symptoms following exposure to an inert substance, which are triggered or exacerbated by psychological mechanisms such as expectations (Kennedy, 1961). The name 'nocebo' was created to distinguish between the desirable ('placebo') and undesirable effects of an inert exposure (Hauser, Hansen, & Enck, 2012), alth...